title: Report on the first PVL-positive community acquired MRSA strain in Latvia.
abstract: Infections by community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) have been reported worldwide. Here we present characterisation of the first CA-MRSA isolated in Latvia. A PVL-positive ST30-MRSA-IV strain was isolated from a nasal swab and the central venous catheter of a patient with fever and multiple organ failure. The PFGE pattern of this strain was identical to pattern SE00-3 of MRSA isolated in Sweden from 29 patients during 2000-2003. This strain is related to the South Pacific area, and its appearance in Sweden and Latvia demonstrates its global spread.
authors.affiliation: P. Stradins Clinical University Hospital, Riga, Latvia.
authors.forename: E
authors.initials: E
authors.lastname: Miklasevics
authors.forename: S
authors.initials: S
authors.lastname: Haeggman
authors.forename: A
authors.initials: A
authors.lastname: Balode
authors.forename: B
authors.initials: B
authors.lastname: Sanchez
authors.forename: A
authors.initials: A
authors.lastname: Martinsons
authors.forename: B
authors.initials: B
authors.lastname: Olsson-Liljequist
authors.forename: U
authors.initials: U
authors.lastname: Dumpis
mesh_terms: D001427:Bacterial Toxins; D002405:Catheterization, Central Venous; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D005098:Exotoxins; D006801:Humans; D007844:Latvia / Q000453:epidemiology; D007956:Leukocidins; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D013211:Staphylococcus aureus / Q000737:chemistry* / Q000187:drug effects / Q000302:isolation & purification
chemical_list: D001427:Bacterial Toxins; D005098:Exotoxins; D007956:Leukocidins; C078284:Panton-Valentine leukocidin